milestones News
Most Popular milestones Story
Pfizer, Avant ink $440M cancer vax deal
Avant Immunotherapeutics is pocketing a $40 million upfront fee and a $10 million equity stake from Pfizer in exchange for the worldwide rights to Avant's experimental brain cancer vaccine. And Read more...
Latest Headlines
- August 11, 2011
- July 21, 2010
- April 14, 2010
- October 23, 2009
- October 19, 2009
- August 12, 2009
- July 24, 2009
- July 10, 2009
- March 3, 2009
- December 12, 2008
- November 24, 2008
- November 6, 2008
- October 30, 2008
- October 14, 2008
- July 15, 2008
- June 12, 2008
- June 5, 2008
- June 5, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
